# A Study in Participants With Non-cirrhotic NASH With Fibrosis

> **NCT05638737** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 112 (actual)

## Conditions studied

- Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

## Interventions

- **DRUG:** AZD4831
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05638737
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-26
- **Primary completion:** 2024-04-04
- **Final completion:** 2024-04-04
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05638737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05638737, "A Study in Participants With Non-cirrhotic NASH With Fibrosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05638737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*